Close Menu

NEW YORK (GenomeWeb News) – Agilent Technologies and WiCell said today they are teaming up to offer comparative genomic hybridization plus single nucleotide polymorphism microarray analysis services using the Agilent SurePrint G3 Human Genome CGH+SNP Microarray.

The microarray detects copy number changes by both SNP and CGH while simultaneously delivering copy-neutral change information such as loss or absence of heterozygosity, the companies said. They added that the assay maintains the high-resolution quality achieved with CGH-only microarrays.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.

Mar
17
Sponsored by
IONPath

In this webinar, Felix J. Hartmann of Stanford University will describe an approach that characterizes the metabolic regulome of individual cells together with their phenotypic identity.